Su L - Search Results

1

Platelet count mediates the contribution of a genetic variant in LRRC16A to ARDS risk.

Wei Y, Wang Z, Su L, Chen F, Tejera P, Bajwa EK, Wurfel MM, Lin X, Christiani DC. Wei Y, et al. Among authors: su l. Chest. 2015 Mar;147(3):607-617. doi: 10.1378/chest.14-1246. Chest. 2015. PMID: 25254322 Free PMC article.

2

Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.

Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: su l. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):15-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815396

3

Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: su l. Cancer Res. 2002 Mar 1;62(5):1377-81. Cancer Res. 2002. PMID: 11888908

4

Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk.

Miller DP, Liu G, De Vivo I, Lynch TJ, Wain JC, Su L, Christiani DC. Miller DP, et al. Among authors: su l. Cancer Res. 2002 May 15;62(10):2819-23. Cancer Res. 2002. PMID: 12019159

5

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Xu LL, et al. Among authors: su l. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1555-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496043

6

No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk.

Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. Su L, et al. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):174-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582031 Clinical Trial. No abstract available.

7

Association between self-reported environmental tobacco smoke exposure and lung cancer: modification by GSTP1 polymorphism.

Miller DP, De Vivo I, Neuberg D, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Among authors: su l. Int J Cancer. 2003 May 10;104(6):758-63. doi: 10.1002/ijc.10989. Int J Cancer. 2003. PMID: 12640684

8

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Among authors: su l. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111

9

P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.

Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Lung Cancer. 2003 Jun;40(3):259-66. doi: 10.1016/s0169-5002(03)00081-3. Lung Cancer. 2003. PMID: 12781424

10

Smoking and the risk of lung cancer: susceptibility with GSTP1 polymorphisms.

Miller DP, Neuberg D, de Vivo I, Wain JC, Lynch TJ, Su L, Christiani DC. Miller DP, et al. Among authors: su l. Epidemiology. 2003 Sep;14(5):545-51. doi: 10.1097/01.ede.0000073120.46981.24. Epidemiology. 2003. PMID: 14501269

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,529 results

Search Page

Filters